Cargando…

Nationwide Study of Sex Differences in Incident Heart Failure in Newly Diagnosed Nonvalvular Atrial Fibrillation

BACKGROUND: Heart failure (HF) is a leading complication of nonvalvular atrial fibrillation (NVAF), and the presence of both conditions worsens prognosis. Sex-specific associations between NVAF and outcomes focus on stroke; less is known about HF. We evaluated sex differences in incident HF in NVAF....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yogasundaram, Haran, Islam, Sunjidatul, Dover, Douglas C., Hawkins, Nathaniel M., Ezekowitz, Justin, Kaul, Padma, Sandhu, Roopinder K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402965/ https://www.ncbi.nlm.nih.gov/pubmed/36035738 http://dx.doi.org/10.1016/j.cjco.2022.04.010

Ejemplares similares

Trends in Uptake and Adherence to Oral Anticoagulation for Patients With Incident Atrial Fibrillation at High Stroke Risk Across Health Care Settings
por: Yogasundaram, Haran, et al.
Publicado: (2022)

A Population-Based Study of Unexplained/Lone Atrial Fibrillation: Temporal Trends, Management, and Outcomes
por: Roston, Thomas M., et al.
Publicado: (2021)

Impact of Rural Residence on Warfarin Use and Clinical Events in Patients with Non-Valvular Atrial Fibrillation: A Canadian Population Based Study
por: Wu, Cynthia, et al.
Publicado: (2015)

Incidence of Syncope During Pregnancy: Temporal Trends and Outcomes
por: Chatur, Safia, et al.
Publicado: (2019)

Detecting Patients With Nonvalvular Atrial Fibrillation and Atrial Flutter in the Canadian Primary Care Sentinel Surveillance Network: First Steps
por: Queenan, John A., et al.
Publicado: (2020)

Cost‐Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation
por: Lau, Darren, et al.
Publicado: (2021)

Surveillance for Outcomes Selected as Atrial Fibrillation Quality Indicators in Canada: 10-Year Trends in Stroke, Major Bleeding, and Heart Failure
por: Wilton, Stephen B., et al.
Publicado: (2021)

Appropriateness of rivaroxaban and apixaban dosing in hospitalized patients with a newly diagnosed nonvalvular atrial fibrillation at a single tertiary hospital
por: Alshibani, Mohannad
Publicado: (2023)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

Hospital Admissions, Costs, and 30-Day Readmissions Among Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran Etexilate or Warfarin
por: Fonseca, Eileen, et al.
Publicado: (2015)

Factors associated with primary nonadherence to newly initiated direct oral anticoagulants in patients with nonvalvular atrial fibrillation
por: Charlton, Alethea, et al.
Publicado: (2021)

Right atrium thrombosis in nonvalvular permanent atrial fibrillation
por: Bălăceanu, A.
Publicado: (2011)

Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
por: Sen, Souvik, et al.
Publicado: (2014)

Population Pharmacokinetics of Apixaban in Subjects With Nonvalvular Atrial Fibrillation
por: Cirincione, Brenda, et al.
Publicado: (2018)

Altered profile of circulating microparticles in nonvalvular atrial fibrillation
por: Siwaponanan, Panjaree, et al.
Publicado: (2019)

Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Collado, Fareed Moses S., et al.
Publicado: (2021)

Impact of Socioeconomic Status and Residence Distance on Infant Heart Disease Outcomes in Canada
por: Olugbuyi, Oluwayomi, et al.
Publicado: (2022)

Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007)

Nonvalvular atrial fibrillation in India—time to pause, think, and change!
por: Singh, Balbir
Publicado: (2018)

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Patel, Priya, et al.
Publicado: (2017)

Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021)

Newly diagnosed atrial fibrillation and hospital utilization in heart failure: a nationwide cohort study
por: Vinter, Nicklas, et al.
Publicado: (2021)

Massive Left Atrial Thrombi during Dabigatran Therapy for Nonvalvular Atrial Fibrillation
por: Bachvarova, Velislava, et al.
Publicado: (2017)

Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United States
por: Jain, Rahul, et al.
Publicado: (2018)

Use of Guideline-Directed Medical Therapy in Patients Aged ≥ 65 Years After the Diagnosis of Heart Failure: A Canadian Population-Based Study
por: Wahid, Muizz, et al.
Publicado: (2022)

Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction
por: Obayashi, Yuki, et al.
Publicado: (2021)

Exercise and the Risk of Dementia in Patients with Newly Diagnosed Atrial Fibrillation: A Nationwide Population-Based Study
por: Lim, Jaehyun, et al.
Publicado: (2021)

Gender-related Differences in Management of Nonvalvular Atrial Fibrillation in an Asian Population
por: Lee, Jung Myung, et al.
Publicado: (2018)

Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation
por: Kyriakou, Elias, et al.
Publicado: (2018)

Secondary Prevention of Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study
por: De Vecchis, Renato, et al.
Publicado: (2019)

Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
por: Perreault, Sylvie, et al.
Publicado: (2019)

Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease
por: Fukamachi, Daisuke, et al.
Publicado: (2022)

Evaluation of New Potential Inflammatory Markers in Patients with Nonvalvular Atrial Fibrillation
por: Martins, Gabriela Lopes, et al.
Publicado: (2023)

Cost Implications of Formulary Decisions on Oral Anticoagulants in Nonvalvular Atrial Fibrillation
por: Biskupiak, Joseph, et al.
Publicado: (2013)

Health Care Burden of Dyspepsia Among Nonvalvular Atrial Fibrillation Patients
por: Kim, Michael H., et al.
Publicado: (2014)

Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
por: Yu, Yunan, et al.
Publicado: (2022)

Effects of Left Atrial Appendage Closure on Neuroendocrine Function in Patients with Nonvalvular Atrial Fibrillation
por: Wang, Fei, et al.
Publicado: (2022)

The Current and Future Hospitalization Cost Burden of Syncope in Canada
por: Tran, Dat T., et al.
Publicado: (2020)

Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
por: Sandhu, Roopinder K, et al.
Publicado: (2018)

Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
por: Zhou, Xue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pv0j7f62qnlubvee0hva4ss9gl